Wells Fargo slashes the target price on Teladoc Health Inc.(TDOC:NYE) to $40

STA Research
by: STA Research

Wells Fargo downgrades Teladoc Health Inc. stock to Equal Weight from Overweight and slashes the target price to $40 from $104 on the company’s stock.

Based on the Teladoc Health Inc stock forecasts from 29 analysts, the average analyst target price for Teladoc Health Inc is USD 0.00 over the next 12 months. Teladoc Health Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Teladoc Health Inc is Slightly Bullish , which is based on 5 positive signals and 3 negative signals. At the last closing, Teladoc Health Inc’s stock price was USD 55.99Teladoc Health Inc’s stock price has changed by -9.24% over the past week, -16.07% over the past month and -70.52% over the last year.

What we like:

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What we don’t like:

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector.

 

Disclaimer

Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.

Leave a Reply

Your email address will not be published.